PGTai Results for Embryos Cultured in Sequential Versus Single Step Media

Sponsor
Ganin Fertility Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT04485910
Collaborator
(none)
200
1
2
18
11.1

Study Details

Study Description

Brief Summary

A prospective cohort study undergoing ICSI at a private fertility center in Egypt

Condition or Disease Intervention/Treatment Phase
  • Other: Single step media
  • Other: Sequential media
N/A

Detailed Description

Purpose:

To evaluate PGTai results for embryos cultured in sequential versus single step media.

Method:

Injected oocytes will divided between Continuous Single Culture-NX media (CSC- NX) with 10% SSS the first group (Irvine, USA) and the other group will be cultured in sequential cleavage and blastocyst media with 10% SPS (SAGE, Denmark).

All blastocytes with 4BB quality and better according to Gardner's criteria 1999 will go through PGTA procedures with PGTai confirmation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Evaluating the embryonic development and PGTai results for embryos cultured in sequential media versus single step media.Evaluating the embryonic development and PGTai results for embryos cultured in sequential media versus single step media.
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Sequential Versus Single Step Culture Media in Relation to Euploidy Rates in PGTai Program
Actual Study Start Date :
Dec 1, 2019
Anticipated Primary Completion Date :
Mar 1, 2021
Anticipated Study Completion Date :
Jun 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Single step media

Embryos cultured in single step media

Other: Single step media
Usage of single step media in embryo culture

Active Comparator: Sequential media

Embryos cultured in sequential media

Other: Sequential media
Usage of sequential media in embryo culture

Outcome Measures

Primary Outcome Measures

  1. Euploidy rate [5:7 days of intracytoplasmic sperm injection(ICSI)]

    percentage of euploid embryos/ total genetic tested embryos on blast stage

  2. Mosaicism rate [5:7 days of ICSI]

    percentage of mosaic embryos/ total genetic tested embryos on blast stage

Secondary Outcome Measures

  1. Fertilization rate [16:19 hours of ICSI]

    Percentage of fertilized oocyte (appearance of two pronuclei) / Number of injected oocytes

  2. Cleavage stage [72 hours of ICSI]

    Percentage of cleaved embryos/ total number of fertilized oocytes

  3. High quality of cleaved embryos [72 hours of ICSI]

    High quality D3 embryos according to Gardner's criteria / total cleaved embryos

  4. Blast formation rate [5:7 days of ICSI]

    Percentage of total blastocysts / Total cleaved embryos

  5. High quality blast rate [5:7 days of ICSI]

    Morphological grading of trophectoderm and Inner cell mass using Gardner's criteria 1999, from grade A and B ( A is the highest quality). Total high grade embryos/ total blast embryos.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 37 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Female age ≤37 years with ≥ 8 mature oocytes

  • Male partner had normal semen parameters according to WHO 2010

  • PGT-A was done at the blastocyst stage

Exclusion Criteria:
  • sperm or oocyte donor

  • severe male factors according to WHO 2010

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ganin Fertility Center Cairo Egypt 11728

Sponsors and Collaborators

  • Ganin Fertility Center

Investigators

  • Principal Investigator: Manar M Hozyen, MSc., Ganin Fertility Center
  • Principal Investigator: Amr Elshimy, BSc., Ganin Fertility Center
  • Principal Investigator: Hanaa Elkhader, BSc., Ganin Fertility Center
  • Study Chair: Hosam Zaki, MSc., Ganin Fertility Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ganin Fertility Center
ClinicalTrials.gov Identifier:
NCT04485910
Other Study ID Numbers:
  • MH0004
First Posted:
Jul 24, 2020
Last Update Posted:
Jul 24, 2020
Last Verified:
Jun 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ganin Fertility Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 24, 2020